These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10372507)

  • 1. GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses.
    Keverne EB
    Brain Res Bull; 1999 Mar; 48(5):467-73. PubMed ID: 10372507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and anatomical aspects of prefrontal pathology in schizophrenia.
    Goldman-Rakic PS; Selemon LD
    Schizophr Bull; 1997; 23(3):437-58. PubMed ID: 9327508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia.
    Javanbakht A
    Med Hypotheses; 2006; 67(5):1173-84. PubMed ID: 16824690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct origin of GABA-ergic neurons in forebrain of man, nonhuman primates and lower mammals.
    Petanjek Z; Dujmović A; Kostović I; Esclapez M
    Coll Antropol; 2008 Jan; 32 Suppl 1():9-17. PubMed ID: 18405052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA through the ages: regulation of cortical function and plasticity by inhibitory interneurons.
    Lehmann K; Steinecke A; Bolz J
    Neural Plast; 2012; 2012():892784. PubMed ID: 22792496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia.
    Daskalakis ZJ; Fitzgerald PB; Christensen BK
    Brain Res Rev; 2007 Dec; 56(2):427-42. PubMed ID: 17980435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia.
    Morishita H; Kundakovic M; Bicks L; Mitchell A; Akbarian S
    Neurobiol Learn Mem; 2015 Oct; 124():104-10. PubMed ID: 25849095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitters in the cerebral cortex.
    Jones EG
    J Neurosurg; 1986 Aug; 65(2):135-53. PubMed ID: 2873211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.
    Hasan A; Wobrock T; Grefkes C; Labusga M; Levold K; Schneider-Axmann T; Falkai P; Müller H; Klosterkötter J; Bechdolf A
    Biol Psychiatry; 2012 Nov; 72(9):744-51. PubMed ID: 22502988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical localization of dopamine D4 receptors in the rat brain--immunocytochemical study.
    Wedzony K; Chocyk A; Maćkowiak M; Fijał K; Czyrak A
    J Physiol Pharmacol; 2000 Jun; 51(2):205-21. PubMed ID: 10898094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA-ergic interneurons of the striatum express the Shaw-like potassium channel Kv3.1.
    Lenz S; Perney TM; Qin Y; Robbins E; Chesselet MF
    Synapse; 1994 Sep; 18(1):55-66. PubMed ID: 7825124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of GABAergic inhibition and synchronization of inhibitory interneurons in rat neocortex.
    Benardo LS
    J Neurophysiol; 1997 Jun; 77(6):3134-44. PubMed ID: 9212263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-immunoreactive axon varicosities form nonrandom contacts with GABA-immunoreactive neurons of rat medial prefrontal cortex.
    Benes FM; Vincent SL; Molloy R
    Synapse; 1993 Dec; 15(4):285-95. PubMed ID: 8153876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder.
    Benes FM; Berretta S
    Neuropsychopharmacology; 2001 Jul; 25(1):1-27. PubMed ID: 11377916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
    Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
    Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenia and cortical GABA neurotransmission].
    Hashimoto T; Matsubara T; Lewis DA
    Seishin Shinkeigaku Zasshi; 2010; 112(5):439-52. PubMed ID: 20560363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy.
    Włodarczyk A; Szarmach J; Cubała WJ; Wiglusz MS
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):345-348. PubMed ID: 28953788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.
    Squires RF; Saederup E
    Neurochem Res; 1991 Oct; 16(10):1099-111. PubMed ID: 1686635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is psychosis a neurobiological syndrome?
    Fujii DE; Ahmed I
    Can J Psychiatry; 2004 Nov; 49(11):713-8. PubMed ID: 15633848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A theoretical and neurophysiological consideration on the pathogenesis of positive symptoms of schizophrenia: implications of dopaminergic function in the emotional circuit.
    Maeda H
    Jpn J Psychiatry Neurol; 1994 Mar; 48(1):99-110. PubMed ID: 7933723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.